TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies.

We have developed C-STEMTM :  a proprietary technology for the mass-production of cell therapies.

Our offer

Cell therapy pipeline

A series of proprietary cell therapy programs for co-development or licensing

C-Stem™ platform

A cGMP-compatible mass-production platform for cell therapies

Latest news

  • En étroite collaboration avec l’ingénieur R&D encapsulation/micro-fabrication, vous participerez à l’optimisation du dispositif d’encapsulation, à la frontière entre la recherche et le développement. Cette mission à forte composante expérimentale recouvre les axes suivants : - Mise en place de techniques de caractérisation des écoulements micro-fluidiques - Optimisation des dispositifs micro-fluidiques - Utilisation de techniques de pointe en micro-fabrication - Interaction avec la bio-production...

  • Following an international career in the pharma industry (GSK, Sanofi, Oenobiol), Jean-Luc Treillou co-founded microbiome company LNC therapeutics in 2011, eventually raising 16.5M€ as CEO & Chairman. In 2018, he co-founded TreeFrog Therapeutics with Maxime Feyeux & Kevin Alessandri, taking in charge governance and investor......

  • Today, Andrea Leonoard, Senior Scientist at TreeFrog Therapeutics was in London, UK to speak at the 3D Cell Culture Conference. She gave an invited presentation about the C-Stem™, our 3D technology for stem cell mass-production.    ...

I am test text for Image with text shortcode.

TreeFrog Therapeutics I Stem Cell Company I Cell Therapy for all

TreeFrog Therapeutics is a stem cell company based in Bordeaux, France, which aims at supporting the advent and industrial development of stem cell therapies. TreeFrog Therapeutics has developed C-Stem, a technology platform to scale-up cell therapy manufacturing. Based on high throughput stem cell encapsulation, C-Stem enables the mass production of human induced pluripotent stem cells (iPSCs) and  mesenchymal stem cells (MSCs) in bioreactors, as well as their differentiation into the desired cell type. Founded by Kevin Alessandri and Maxime Feyeux, TreeFrog Therapeutics is a startup company which aims at providing access to cell therapies for all.